These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10226867)

  • 1. Bradykinin-dependent cardioprotective effects of losartan against ischemia and reperfusion in rat hearts.
    Zhu P; Zaugg CE; Hornstein PS; Allegrini PR; Buser PT
    J Cardiovasc Pharmacol; 1999 May; 33(5):785-90. PubMed ID: 10226867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of the angiotensin-converting enzyme inhibitor captopril on postischemic myocardial damage in perfused rat heart.
    Takeda H; Haneda T; Kikuchi K
    Jpn Circ J; 1997 Aug; 61(8):687-94. PubMed ID: 9276774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
    Wang QD; Sjöquist PO
    Eur J Pharmacol; 1999 Sep; 380(1):13-21. PubMed ID: 10513555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms.
    Sato M; Engelman RM; Otani H; Maulik N; Rousou JA; Flack JE; Deaton DW; Das DK
    Circulation; 2000 Nov; 102(19 Suppl 3):III346-51. PubMed ID: 11082412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA.
    Yang BC; Phillips MI; Zhang YC; Kimura B; Shen LP; Mehta P; Mehta JL
    Circ Res; 1998 Sep; 83(5):552-9. PubMed ID: 9734478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: evidence of an e-NOS mRNA overexpression after global ischemia.
    Barsotti A; Di Napoli P; Taccardi AA; Spina R; Stuppia L; Palka G; Barbacane RC; De Caterina R; Conti P
    Atherosclerosis; 2001 Mar; 155(1):53-9. PubMed ID: 11223426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts.
    Kawabata H; Ryomoto T; Ishikawa K
    Hypertens Res; 2001 Jul; 24(4):403-9. PubMed ID: 11510753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cardiac ATP-sensitive K+ channels induced by angiotensin II type 1 receptor antagonist on metabolism, contraction and relaxation in ischemia-reperfused rabbit heart.
    Kawabata H; Ryomoto T; Ishikawa K
    Jpn Circ J; 2001 May; 65(5):451-6. PubMed ID: 11348052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite effects of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts.
    Ford WR; Clanachan AS; Jugdutt BI
    Circulation; 1996 Dec; 94(12):3087-9. PubMed ID: 8989113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AT(1) and AT(2) receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts.
    Xu Y; Kumar D; Dyck JR; Ford WR; Clanachan AS; Lopaschuk GD; Jugdutt BI
    Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1206-15. PubMed ID: 11893553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradykinin accounts for improved postischemic function and decreased glutathione release of guinea pig heart treated with the angiotensin-converting enzyme inhibitor ramiprilat.
    Massoudy P; Becker BF; Gerlach E
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):632-9. PubMed ID: 7516015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury.
    Yoshiyama M; Kim S; Yamagishi H; Omura T; Tani T; Yanagi S; Toda I; Teragaki M; Akioka K; Takeuchi K
    Am Heart J; 1994 Jul; 128(1):1-6. PubMed ID: 8017262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the angiotensin II subtype 1 receptor antagonist losartan on functional recovery of isolated rat hearts undergoing global myocardial ischemia-reperfusion.
    Flynn JD; Akers WS
    Pharmacotherapy; 2003 Nov; 23(11):1401-10. PubMed ID: 14620386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinaprilat during cardioplegic arrest in the rabbit to prevent ischemia-reperfusion injury.
    Korn P; Kröner A; Schirnhofer J; Hallström S; Bernecker O; Mallinger R; Franz M; Gasser H; Wolner E; Podesser BK
    J Thorac Cardiovasc Surg; 2002 Aug; 124(2):352-60. PubMed ID: 12167796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiotensin converting enzyme inhibition with quinaprilat on the ischaemic and reperfused myocardium.
    Cargnoni A; Boraso A; Scotti C; Ghirardelli N; Benigno M; Bernocchi P; Pedersini P; Ferrari R
    J Mol Cell Cardiol; 1994 Jan; 26(1):69-86. PubMed ID: 8196071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an endothelin receptor antagonist and an angiotensin converting enzyme inhibitor on metabolism and contraction in the ischemic and reperfused rabbit heart.
    Kawabata H; Ryomoto T; Ishikawa K
    Jpn Circ J; 1999 Oct; 63(10):770-4. PubMed ID: 10553919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W; Martorana PA; Schölkens BA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent losartan administration triggers cardiac post-conditioning in isolated rat hearts: role of BK2 receptors.
    Sgarra L; Leo V; Addabbo F; Iacobazzi D; Carratù MR; Montagnani M; Potenza MA
    PLoS One; 2014; 9(2):e88542. PubMed ID: 24520397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.